Semin Thromb Hemost 2022; 48(02): 127-131
Editorial Compilation XI
1
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR),
Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, Australia
,
2
Section of Clinical Biochemistry, University of Verona, Verona, Italy
› Author Affiliations
References
1
Szabó G,
Antal-Szalmás P,
Kerényi A,
Pénzes K,
Bécsi B,
Kappelmayer J.
Thrombin: Laboratory approaches to test the function of antiphospholipid antibodies.
Semin Thromb Hemost 2022; 48 (02) 132-144 2
Moore GW.
Snake venoms in diagnostic haemostasis and thrombosis. Semin Thromb Hemost 2022; 48
(02) 145-160 3
Bor MV,
Feddersen S,
Pedersen IS,
Sidelmann JJ,
Kristensen SR.
Dysfibrinogenemia – potential impact of genotype on thrombosis or bleeding. Semin
Thromb Hemost 2021; 48 (02) 161-173 4
Kearney KJ,
Ariëns RAS,
Macrae FL.
The role of fibrin(ogen) in wound healing and infection control. Semin Thromb Hemost
2021; 48 (02) 174-187 5
Favaloro EJ.
2018 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin
Thromb Hemost 2019; 45 (02) 123-129 6
Maphumulo SC,
Pretorius E.
Role of circulating microparticles in type 2 diabetes mellitus: implications for pathological
clotting. Semin Thromb Hemost 2022; 48 (02) 188-205 7
Ichinose A,
Osaki T,
Souri M.
A review of coagulation abnormalities of autoimmune acquired factor V deficiency with
a focus on Japan. Semin Thromb Hemost 2022; 48 (02) 206-218 8
Pierce-Williams RAM,
Makhamreh MM,
Blakey-Cheung S,
Gao Z,
Al-Kouatly HB.
Postpartum hemorrhage in patients with type 1 von Willebrand disease: A systematic
review. Semin Thromb Hemost 2022; 48 (02) 219-228 9
Krag AE,
Hvas CL,
Kiil BJ,
Hvas A-M.
Effect of remote ischemic conditioning on bleeding complications in surgery: a systematic
review and meta-analysis. Semin Thromb Hemost 2021; 48 (02) 229-239 10
Thachil J.
Protamine – the journey from DNA to heparin neutralisation to gene therapy. Semin
Thromb Hemost 2022; 48 (02) 240-243 11
Guillermo Ruiz-ArgüelleJ..
Démonstration de faisabilité: Non-alcoholic fatty liver disease may cause thrombocytopenia.
Semin Thromb Hemost 2022; 48 (02) 244-245 12
Limami Y,
Senhaji N,
Zaid N.
et al.
PKC-delta-dependent pathways contribute to the exacerbation of the platelet activity
in Crohn's disease. Semin Thromb Hemost 2022; 48 (02) 246-250 13
Horneff R,
Bystrická L,
Santagostino E,
Lethagen S,
Casiano S.
Comment on “Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia
A: Insights from Pivotal and Extension Studies”. Semin Thromb Hemost 2022; 48 (02)
251-252 14
Di Minno MND,
Di Minno A,
Calcaterra I,
Cimino E,
Dell'Aquila F,
Franchini M.
Enhanced half-life recombinant factor VIII concentrates for hemophilia A: insights
from pivotal and extension studies. Semin Thromb Hemost 2021; 47 (01) 32-42 15
Di Minno MND,
Di Minno A,
Calcaterra I,
Cimino E,
Dell'Aquila F,
Franchini M.
Enhanced half-life recombinant factor VIII concentrates for hemophilia A: final results
from extension studies. Semin Thromb Hemost 2022; 48 (02) 253-255 16
Chen JK,
Tang N,
Wang X,
Huang M,
Zhang C.
A case of parturient with hereditary thrombotic thrombocytopenic purpura: case report
of a novel variant. Semin Thromb Hemost 2021; 48 (02) 256-261 17
Thachil J,
Triantafillou M,
Bristogiannis S.
Why ‘the love of blood’ in Haemophilia?. Semin Thromb Hemost 2022; 48 (02) 262-264
